Modulation of the effect of anthracycline efficacy and toxicity by ICRF-187

Cancer Invest. 1990;8(2):267-8. doi: 10.3109/07357909009017580.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Drug Synergism
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Humans
  • Piperazines / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Razoxane / administration & dosage*

Substances

  • Piperazines
  • Razoxane
  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil

Supplementary concepts

  • CAF protocol